With kisspeptin highlighting another layer of complexity, researchers are also focusing on safety considerations around PT-141 for Women in research
Kurosawa, K., Hayashi, N., Sato, N., Kamada, T
IGF-1 DES + Testosterone: Testosterone provides the systemic anabolic foundation while IGF-1 DES targets weak points with localized hyperplasia
When a product claims that a peptide the size of semaglutide crosses your skin from a patch, it is working directly against basic pharmacology, and understanding this one fact makes most patch marketing fall apart on contact, before you even read the ingredient list
Women who should avoid PT-141 or only use it under close medical supervision include those with: Uncontrolled hypertension Significant cardiovascular disease Known hypersensitivity to melanocortin peptides A history of severe adverse reactions to injectable therapies Pregnancy or breastfeeding PT-141 can cause temporary increases in blood pressure shortly after administration, which is why cardiovascular screening is an important part of the evaluation process